Morrie M. Gelfand

4.1k total citations · 1 hit paper
56 papers, 2.9k citations indexed

About

Morrie M. Gelfand is a scholar working on Endocrinology, Diabetes and Metabolism, Obstetrics and Gynecology and Genetics. According to data from OpenAlex, Morrie M. Gelfand has authored 56 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Endocrinology, Diabetes and Metabolism, 16 papers in Obstetrics and Gynecology and 12 papers in Genetics. Recurrent topics in Morrie M. Gelfand's work include Menopause: Health Impacts and Treatments (19 papers), Estrogen and related hormone effects (12 papers) and Phytoestrogen effects and research (7 papers). Morrie M. Gelfand is often cited by papers focused on Menopause: Health Impacts and Treatments (19 papers), Estrogen and related hormone effects (12 papers) and Phytoestrogen effects and research (7 papers). Morrie M. Gelfand collaborates with scholars based in Canada, United States and United Kingdom. Morrie M. Gelfand's co-authors include Alex Ferenczy, B B Sherwin, B. B. Sherwin, William Brender, Barbara B. Sherwin, Apostolos Papageorgiou, Cynthia G. Goodyer, Mark Trifiro, M Guralnick and Jennifer Hammond and has published in prestigious journals such as PEDIATRICS, Pain and Journal of Clinical Microbiology.

In The Last Decade

Morrie M. Gelfand

53 papers receiving 2.7k citations

Hit Papers

Androgen enhances sexual ... 1985 2026 1998 2012 1985 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Morrie M. Gelfand Canada 23 1.1k 611 596 536 509 56 2.9k
Janice Rymer United Kingdom 33 1.2k 1.1× 853 1.4× 453 0.8× 251 0.5× 343 0.7× 113 3.0k
Lynne T. Shuster United States 31 1.7k 1.5× 1.3k 2.1× 885 1.5× 378 0.7× 241 0.5× 54 3.8k
James Liu United States 31 732 0.6× 368 0.6× 881 1.5× 380 0.7× 369 0.7× 119 2.8k
Costantino Di Carlo Italy 36 619 0.5× 405 0.7× 1.4k 2.3× 1.1k 2.1× 453 0.9× 197 4.4k
E Cacciari Italy 38 1.8k 1.6× 1.3k 2.1× 792 1.3× 250 0.5× 806 1.6× 146 4.9k
Florence Comite United States 28 475 0.4× 249 0.4× 1.2k 2.0× 592 1.1× 253 0.5× 63 2.3k
John E. Tyson United States 29 1.4k 1.2× 228 0.4× 460 0.8× 475 0.9× 495 1.0× 81 2.9k
Peter C. Hindmarsh United Kingdom 43 2.9k 2.6× 1.0k 1.7× 383 0.6× 422 0.8× 460 0.9× 172 5.4k
Jean De Schepper Belgium 38 1.3k 1.2× 1.2k 1.9× 583 1.0× 146 0.3× 648 1.3× 185 4.3k
J. W. W. Studd United Kingdom 20 624 0.6× 425 0.7× 356 0.6× 208 0.4× 153 0.3× 61 1.8k

Countries citing papers authored by Morrie M. Gelfand

Since Specialization
Citations

This map shows the geographic impact of Morrie M. Gelfand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Morrie M. Gelfand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Morrie M. Gelfand more than expected).

Fields of papers citing papers by Morrie M. Gelfand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Morrie M. Gelfand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Morrie M. Gelfand. The network helps show where Morrie M. Gelfand may publish in the future.

Co-authorship network of co-authors of Morrie M. Gelfand

This figure shows the co-authorship network connecting the top 25 collaborators of Morrie M. Gelfand. A scholar is included among the top collaborators of Morrie M. Gelfand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Morrie M. Gelfand. Morrie M. Gelfand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Gelfand, Morrie M., et al.. (2003). Clinical assessment and quality of life of postmenopausal women treated with a new intermittent progestogen combination hormone replacement therapy: a placebo-controlled study. Menopause The Journal of The North American Menopause Society. 10(1). 29–36. 30 indexed citations
3.
Ferenczy, Alex, Morrie M. Gelfand, P. H. M. van de Weijer, & Jacques E. Rioux. (2002). Endometrial safety and bleeding patterns during a 2-year study of 1 or 2 mg 17β-estradiol combined with sequential 5-20 mg dydrogesterone. Climacteric. 5(1). 26–35. 16 indexed citations
4.
Rioux, Jacques E., et al.. (2000). 17β-Estradiol Vaginal Tablet Versus Conjugated Equine Estrogen Vaginal Cream to Relieve Menopausal Atrophic Vaginitis. Menopause The Journal of The North American Menopause Society. 7(3). 156–161. 130 indexed citations
5.
Gelfand, Morrie M.. (1999). Role of androgens in surgical menopause. American Journal of Obstetrics and Gynecology. 180(3). S325–S327. 17 indexed citations
6.
Rioux, Jacques E., et al.. (1998). P-19. Vagifem vs. Premarin Vaginal Cream. Menopause The Journal of The North American Menopause Society. 5(4). 257–257. 2 indexed citations
7.
Gelfand, Morrie M., P Fugère, & F. Bissonnette. (1997). Cardiovascular risk factors during sequentially combined 17β oestradiol and dydrogesterone (Femoston®); results from a one-year study in postmenopausal women. Maturitas. 26(2). 125–132. 15 indexed citations
8.
Gelfand, Morrie M. & Brinda Wiita. (1997). Androgen and estrogen-androgen hormone replacement therapy: a review of the safety literature, 1941 to 1996. Clinical Therapeutics. 19(3). 383–404. 40 indexed citations
9.
Klein, Michael, Robert Gauthier, James M. Robbins, et al.. (1994). Relationship of episiotomy to perineal trauma and morbidity, sexual dysfunction, and pelvic floor relaxation. American Journal of Obstetrics and Gynecology. 171(3). 591–598. 299 indexed citations
10.
Ferenczy, Alex & Morrie M. Gelfand. (1989). The biologic significance of cytologic atypia in progestogen-treated endometrial hyperplasia. American Journal of Obstetrics and Gynecology. 160(1). 126–131. 165 indexed citations
11.
Tulandi, Togas, et al.. (1988). Closure of laparotomy incisions with or without peritoneal suturing and second-look laparoscopy. American Journal of Obstetrics and Gynecology. 158(3). 536–537. 72 indexed citations
12.
Guralnick, M, et al.. (1986). The effects of transcutaneous electrical nerve Stimulation on post-cesarean pain. Pain. 27(2). 181–193. 62 indexed citations
13.
Sherwin, B. B., Morrie M. Gelfand, & William Brender. (1985). Androgen enhances sexual motivation in females: a prospective, crossover study of sex steroid administration in the surgical menopause.. Psychosomatic Medicine. 47(4). 339–351. 432 indexed citations breakdown →
14.
Tulandi, Togas, et al.. (1984). Reconstructive surgery of hydrosalpinx with and without the carbon dioxide laser. Fertility and Sterility. 42(6). 839–842. 22 indexed citations
15.
Gelfand, Morrie M., et al.. (1982). Cesarean section: recent trends.. PubMed. 25(1). 85–7, 91. 1 indexed citations
16.
17.
Mendelson, John, et al.. (1979). Effect of single and multidose cephradine prophylaxis on infectious morbidity of vaginal hysterectomy.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 53(1). 31–5. 50 indexed citations
18.
Papageorgiou, Apostolos, et al.. (1979). The Antenatal Use of Betamethasone in the Prevention of Respiratory Distress Syndrome: A Controlled Double-Blind Study. PEDIATRICS. 63(1). 73–79. 113 indexed citations
19.
Gelfand, Morrie M., et al.. (1974). Cullen's sign, a feature in liver disease.. BMJ. 1(5906). 493–494. 20 indexed citations
20.
Gelfand, Morrie M., et al.. (1970). Studies on beta thalassemia trait in pregnancy. American Journal of Obstetrics and Gynecology. 108(8). 1217–1223. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026